Crossmark

Comparison of an injectable toltrazuril-gleptoferron (Forceris®) and an oral toltrazuril (Baycox®) + injectable iron dextran for the control of experimentally induced piglet cystoisosporosis

Crossref DOI link: https://doi.org/10.1186/s13071-018-2797-5

Published Online: 2018-03-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Joachim, Anja

Shrestha, Aruna

Freudenschuss, Barbara

Palmieri, Nicola

Hinney, Barbara

Karembe, Hamadi

Sperling, Daniel
License Information

Text and Data Mining valid from 2018-03-27
More Information

Article History

Received: 20 December 2017

Accepted: 15 March 2018

First Online: 27 March 2018

Ethics approval

: The procedures involving piglets for collection of oocysts were approved by the institutional ethics committee and the national authority according to § 26ff of Animal Experiments Act, Tierversuchsgesetz 2012-TVG 2012 (license number: BMWF-68.205/0034-WF/V/3b/2016; Austrian Federal Ministry of Science, Health and Economy).

: Not applicable.

: The authors declare that they have no competing interests. DS and HK are employees of Ceva. No member of the staff of the Vetmeduni Vienna involved in the trial received allowances or other personal benefits from the Sponsor.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below